<?xml version="1.0" encoding="UTF-8"?>
<p id="Par81">In a recent review published by Forton et al. [
 <xref ref-type="bibr" rid="CR28">28</xref>] the HCV-clearance led to a valid improvement of neuropsychiatric manifestations. In disagreement with this study, in a recent Spanish study DAA-treatment had no impact on anxiety or depression during or after chronic hepatitis C infection treatment, even in high-risk patients with major psychiatric disorders [
 <xref ref-type="bibr" rid="CR29">29</xref>]. We cannot confirm this findings as no post-treatment neurospychiatric evaluation was performed; however, in our experience, none of the psychiatric disorders reported during treatment had worsened at the end of treatment.
</p>
